Financials

  • Market Capitalization 6.63 M
  • Employee 41
  • Founded 2007
  • CEO N/A
  • Website www.bioatla.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y6GBT61
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.56
ratio cours/chiffre d'affaires
-180.52

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4908
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.56 USD-1.27%+8.33%-3.70%-18.75%6.70 M USD
4915
CVKD
Cadrenal Therapeutics, Inc. - Common Stock
2.36 USD-2.48%-27.83%-37.89%-57.25%6.77 M USD
4923
XBIO
Xenetic Biosciences, Inc. - Common Stock
2.90 USD+2.11%+2.11%-10.49%-21.62%6.64 M USD
4925
APM
Aptorum Group Limited - Class A Ordinary Shares
0.81 USD0.00%+2.53%-4.71%-13.83%6.60 M USD

Nouvelles